Market Tracker

03/24 5:16pm ET

Clovis Oncology Inc (NASDAQ:CLVS)

70.32
Delayed Data
As of 3:59pm ET
 +1.79 / +2.61%
Today’s Change
11.57
Today|||52-Week Range
74.94
+58.31%
Year-to-Date
Look for Clovis Oncology to Resume Its Advance
Mar 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close68.53
Today’s open68.58
Day’s range68.54 - 70.98
Volume1,327,294
Average volume (3 months)2,179,817
Market cap$3.1B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+41.46%
Earnings growth (next 5 years)+24.51%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.05+0.04%
RAREUltragenyx Pharmaceu...-1.67-2.32%
PBHPrestige Brands Hold...-0.12-0.21%
ICPTIntercept Pharmaceut...+0.93+0.80%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$1.48
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
SVP-Finance, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts